Renal Medullary Carcinoma Awareness By Tina Hayward-White
- October 09, 2022
Cancer research and treatment development are not just about pink ribbons and multi-million dollar nonprofits. There are many types of cancer that are still unknown, even to physicians. 10 years ago, Chris Johnson passed away from Renal Medullary Carcinoma (RMC). At the time, RMC was virtually unknown. There was no research being conducted. There were no treatments being developed. Chris’ mother, Ritchie Johnson, dedicated the past 10 years to creating awareness, establishing a global community for advocacy, and generating financial support for MD Anderson Cancer Center to launch the world’s only research program for RMC. That research led to the development and clinical trials of targeted therapies in the treatment of RMC. The video brings so much hope to hear stories of people who were diagnosed with RMC and who received life-saving treatments thanks to Ritchie’s tireless commitment all of these years, as well as to hear from the doctors at UT MD Anderson Cancer Center.